Mesa Laboratories, a global leader in life science tools, will release its financial results for the fourth quarter and full fiscal year ending March 31, 2026, on May 27, 2026. This announcement is important for investors tracking the company's performance in pharmaceutical and healthcare quality control markets. The results will provide insights into Mesa's business health and future prospects under its new CEO Siddhartha Kadia, appointed earlier in 2026.
After the US and Iran reached a deal expected to reopen the Strait of Hormuz, the world's largest tanker owner, Mitsui OSK Lines, cautions that shipping companies will wait for proof the agreement works before resuming normal traffic. The strait is c...
YieldMax ETFs have announced their weekly distributions for Group 1 ETFs, with distribution rates ranging from about 25% to over 65%. These ETFs focus on option income strategies across sectors like semiconductors, AI, crypto, and metals. Investors s...
QTREX Quantum Ltd announced that its Additively Manufactured Electronics (AME) technology achieved a 97% yield validation at a major U.S. interconnect manufacturer. This milestone confirms the technology's readiness for high-demand production environ...
Clean Energy Fuels Corp. secured contracts to design and install liquefied natural gas (LNG) fueling systems in Puerto Rico, supporting a pharmaceutical manufacturer and P.R. Energy Partners' luxury residential and hotel operations. These projects wi...
Epson introduced the WorkForce Enterprise AM-C10000, a high-speed color multifunction printer capable of printing 100 ISO pages per minute, designed for busy offices and print services requiring precise color control. It supports heavy workloads with...
